Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .
Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .
Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .
Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .
Children's Hospital at Montefiore Medical Center, Bronx, New York, United States
Mazandaran University of medical sciences, Sari, Mazandaran, Iran, Islamic Republic of
Seoul National University Medical School, Seoul, Korea, Republic of
HaEmekMC, Afula, Israel
Geha Mental Health Center, Petach-Tikva, Israel
Medical University of South Carolina, Charleston, South Carolina, United States
Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States
UC San Diego, CTRI, La Jolla, California, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sainte-Foy, Quebec, Canada
Universitair Ziekenhuis Antwerpen, Dermatology, Edegem, Belgium
UZLeuven Gasthuisberg, Leuven, Belgium
Chef de Service du Service Universitaire de Dermatologie, Liège, Belgium
University of Toulouse - Centre de Recherche - Gérontopôle Hôpital La Grave, Toulouse, France
Charité Berlin, Berlin, Germany
University of Coimbra - Clínica Universitária de Reumatologia, Coimbra, Portugal
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.